De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansMITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancerDermatopontin interacts with transforming growth factor beta and enhances its biological activityAntisense targeting of perlecan blocks tumor growth and angiogenesis in vivoSpecificities of three distinct human chondroitin/dermatan N-acetylgalactosamine 4-O-sulfotransferases demonstrated using partially desulfated dermatan sulfate as an acceptor: implication of differential roles in dermatan sulfate biosynthesisExpression of lumican in human colorectal cancer cellsDecorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitopeDecorin is a biological ligand for the epidermal growth factor receptorAnalysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridizationEffect of doublecortin on self-renewal and differentiation in brain tumor stem cells.Complete cDNA cloning, genomic organization, chromosomal assignment, functional characterization of the promoter, and expression of the murine Bamacan gene.Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-rasPresence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturationSyndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment.Stromal reengineering to treat pancreas cancerMitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cellsDecorin induced by progesterone plays a crucial role in suppressing endometriosisProteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycansDecorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesisIntratumoral drug delivery with nanoparticulate carriers.Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in miceDecorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.Decorin-Mediated Inhibition of Human Trophoblast Cells Proliferation, Migration, and Invasion and Promotion of Apoptosis In Vitro.Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.Decorin as a multivalent therapeutic agent against cancer.Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.Dichotomy of decorin activity on the insulin-like growth factor-I systemDecorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.An antimetastatic role for decorin in breast cancer.Matricellular proteins as regulators of cancer metastasis to bone.Decorin is a novel antagonistic ligand of the Met receptor.Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways.Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.Decorin in Human Colon Cancer: Localization In Vivo and Effect on Cancer Cell Behavior In Vitro.Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification.
P2860
Q21710680-E118E3CA-28CD-4AB3-9D3E-73F7A649F436Q24328792-D90EFB72-71E2-46DE-94F3-AAA012F58A0AQ24531375-A524EB25-9330-4086-8B4C-39E2D1282BEFQ24564477-07FCEC87-DACC-42B0-9BE9-46693902AB11Q28185488-8947A3C9-416F-448C-89B8-7F4B2C0EFF01Q28205571-83AFA791-C332-4DBC-97A8-1EB903764F51Q28213528-964EC50E-0D42-4C1B-87AB-05A9E3A4AF14Q28297196-812E6D67-2093-4DC4-9970-8CCE7505BB41Q28344340-93471462-F12F-46BC-B3AC-0A0F8894F0EAQ30501156-C241D388-D9B4-45B7-A6AB-6A71165A103CQ30708458-B5D1A629-2870-4BC4-A0F5-813D3EF340AAQ30830920-3350ADE7-C9CB-45FD-91D4-5771DFF2490BQ33493198-B4A5A326-B10F-43C9-ACF9-667088D99F5DQ33611148-06FD1317-8A1F-45B2-87D1-CBC5E334227EQ33647915-62587FC1-4E36-4DD6-B82E-AEAA6C5F3B8AQ33827708-5A79ACED-2DD3-4BA4-B974-0E1CA8C43779Q33900490-3B41B809-A688-4323-8B7A-095CF92F0971Q34343640-6175D9E2-1631-48AD-A3F6-A6C6A6C7E397Q34398188-1789B36A-23A4-49DC-8BAD-472FF28EAC71Q34439113-15A877D7-619F-4DDD-9194-88D145EB3B4EQ34757824-BDBAF1D6-410A-4502-8013-A15F86A2E0E0Q35065854-7C697B28-D1EC-4193-A257-1E3FBF4C61FBQ35091415-C3CF1AA9-B625-45E4-99F3-2CAAAC15C029Q35730719-DE3E5DCD-F52B-457D-ADE9-78B0ECD97C66Q35773980-A4645B82-A1BE-4373-8218-4825AEC5CBA8Q36017527-9E5F86BE-F6B0-4C30-A771-8C6CF79EE39CQ36258506-AC08FC9C-FCA4-484F-BC56-4B2BCFCD69D6Q36578803-4E97136B-9F3C-4C10-A6CB-78BE674C64E8Q36787608-D6E254D5-630D-489E-9D65-994D7D400434Q36836772-A446F944-929A-4354-ABB4-D28453A69B57Q36836945-CEF45F85-B0A7-4192-9DB4-75439B2B73A5Q36855729-C8761E62-7D6F-458B-8018-1252B9E7EAB1Q36923653-32BFC3BD-E206-48A3-9A1F-29614BE1F9FCQ37263981-D9B11931-E994-4D97-A156-9882A04787BBQ37350645-B8887A83-11D7-452D-ACC4-1A88E5333BCEQ37369777-6EA14920-A459-4912-BF9F-228933CC57F3Q37377590-32A51947-1643-44B7-9ACE-D8B8B7BE41E4Q37636855-6788E654-3BFA-4836-82B6-C7BC8637D5DCQ38871847-3E68936B-1419-46F9-AC81-EE6225C9CFE5Q39500213-8BB700B3-0741-4706-9784-1805F0F3BDA4
P2860
De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
De novo decorin gene expressio ...... pe in human colon cancer cells
@ast
De novo decorin gene expressio ...... pe in human colon cancer cells
@en
De novo decorin gene expressio ...... pe in human colon cancer cells
@nl
type
label
De novo decorin gene expressio ...... pe in human colon cancer cells
@ast
De novo decorin gene expressio ...... pe in human colon cancer cells
@en
De novo decorin gene expressio ...... pe in human colon cancer cells
@nl
prefLabel
De novo decorin gene expressio ...... pe in human colon cancer cells
@ast
De novo decorin gene expressio ...... pe in human colon cancer cells
@en
De novo decorin gene expressio ...... pe in human colon cancer cells
@nl
P2093
P2860
P356
P1476
De novo decorin gene expressio ...... pe in human colon cancer cells
@en
P2093
B Calabretta
E C Lattime
P2860
P304
P356
10.1073/PNAS.92.15.7016
P407
P577
1995-07-01T00:00:00Z